understanding why cll patients stop responding to treatment, and options for salvage therapies
Published 8 years ago • 121 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
5:03
understanding patient perspectives in cll treatment
-
4:57
sequencing of targeted therapies for cll
-
1:18
involving the patient in treatment decisions for cll
-
17:52
diagnosis and initial treatment of cll
-
1:23
managing patients with multiple myeloma who have stopped treatment prior to relapse
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
7:24
what are the current cll treatment options?
-
27:49
what's new with cll treatments w/top expert | dr. william wierda, md anderson | the patient story
-
1:29
the importance of treatment sequencing in cll
-
4:51
current treatment options for cll
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:43
treatment sequencing options for recurrent cll
-
0:56
the current treatment landscape in cll
-
12:46
fixed duration treatment strategies in cll
-
1:51
the major risk factors for infection in cll and exploring strategies to mitigate risk
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:08
an insight into the current understanding of risk factors for cll
-
1:09
current and emerging treatment strategies for cll & defining the optimal treatment duration
-
1:33
key factors affecting treatment decision making in cll
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
3:14
understanding cll pathogenesis by assessing clonotypes